Summary & Overview
HCPCS Level II J0525: Injection, cefotetan disodium, 10 mg
HCPCS Level II code J0525 denotes the injection of cefotetan disodium, 10 mg, a parenteral cephalosporin antibiotic used in a range of clinical settings. Nationally, precise coding for injectable antimicrobials like cefotetan is important for clinical documentation, hospital billing, and pharmacy supply-chain management, and it affects aggregated utilization and payment reporting across payers.
This analysis covers major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, typical sites of service where it is billed, and the clinical context for use. The report also outlines payer coverage considerations and common billing modifiers used with injectable drug administration. Additionally, the publication provides benchmarks and policy-relevant notes on coding practice, reimbursement patterns, and documentation expectations to inform revenue cycle and clinical pharmacy operations.
Data not available in the input is indicated where relevant.
Billing Code Overview
HCPCS Level II code J0525 represents an injection of cefotetan disodium, 10 mg. This code is used to report administration of the specified parenteral antibiotic.
-
Service type: Injectable antibiotic administration
-
Typical site of service: Hospital inpatient, hospital outpatient, emergency department, or other clinical settings where parenteral antibiotics are administered (e.g., infusion centers)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old male with a history of biliary tract surgery presents to the outpatient infusion center with fever, right upper quadrant pain, and elevated white blood cell count. Imaging suggests acute cholangitis with suspected Gram-negative organisms. The attending physician orders intravenous cefotetan for broad-spectrum perioperative and intra-abdominal coverage. Nursing performs medication reconciliation, verifies allergies, obtains informed consent for parenteral antibiotics, and prepares the dose using sterile technique. The drug billed as J0525 (Injection, cefotetan disodium, 10 mg) is administered via peripheral IV or existing central line depending on venous access. Vital signs, infusion tolerance, and post-dose observation are documented. Typical sites of service include hospital inpatient ward, emergency department, ambulatory surgical center for perioperative prophylaxis, or outpatient infusion center for continued therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Standard component | Rarely used on J-codes; indicates usual service without special circumstances |
22 | Increased procedural services | Indicates substantially greater complexity or time required | Use if administration required significantly greater resources (e.g., complex reconstitution, extended monitoring)